Bank Of New York Mellon Corp Kal Vista Pharmaceuticals, Inc. Transaction History

Bank Of New York Mellon Corp

$541 Trillion
Q4 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$4.2 - $14.24 $348,675 - $1.18 Million	83,018 New	83,018 $561,000
Q3 2022 Nov 14, 2022	BUY	$9.85 - $16.83 $94,530 - $161,517	9,597 Added 13.12%	82,732 $1.2 Million
Q2 2022 Aug 15, 2022	BUY	$8.16 - $15.1 $29,090 - $53,831	3,565 Added 5.12%	73,135 $719,000
Q1 2022 May 11, 2022	BUY	$11.2 - $16.97 $42,985 - $65,130	3,838 Added 5.84%	69,570 $1.03 Million
Q4 2021 Feb 11, 2022	SELL	$12.36 - $18.28 $92,749 - $137,173	-7,504 Reduced 10.25%	65,732 $870,000
Q3 2021 Nov 12, 2021	SELL	$17.11 - $24.49 $212,916 - $304,753	-12,444 Reduced 14.52%	73,236 $1.28 Million
Q2 2021 Aug 11, 2021	SELL	$23.12 - $29.91 $573,930 - $742,485	-24,824 Reduced 22.46%	85,680 $2.05 Million
Q1 2021 May 13, 2021	BUY	$14.69 - $42.57 $957,420 - $2.77 Million	65,175 Added 143.78%	110,504 $2.84 Million
Q4 2020 Feb 09, 2021	BUY	$12.88 - $19.47 $41,860 - $63,277	3,250 Added 7.72%	45,329 $860,000
Q3 2020 Nov 12, 2020	SELL	$9.83 - $13.99 $992 - $1,412	-101 Reduced 0.24%	42,079 $529,000
Q2 2020 Aug 12, 2020	BUY	$6.75 - $12.89 $47,999 - $91,660	7,111 Added 20.28%	42,180 $510,000
Q1 2020 May 06, 2020	BUY	$5.8 - $18.56 $406 - $1,299	70 Added 0.2%	35,069 $268,000
Q4 2019 Feb 14, 2020	SELL	$10.31 - $17.81 $19,589 - $33,839	-1,900 Reduced 5.15%	34,999 $623,000
Q3 2019 Nov 07, 2019	SELL	$11.6 - $21.67 $25,369 - $47,392	-2,187 Reduced 5.6%	36,899 $428,000
Q2 2019 Aug 12, 2019	BUY	$18.44 - $30.89 $589,305 - $987,182	31,958 Added 448.34%	39,086 $865,000
Q1 2019 May 14, 2019	BUY	$16.51 - $31.1 $117,683 - $221,680	7,128 New	7,128 $204,000

Others Institutions Holding KALV

# of Institutions

135

Shares Held

52M

Call Options Held

551K

Put Options Held

98K

Vr Adviser, LLC New York, NY

6.25M
Shares

$61 Million
8.73% of portfolio
Suvretta Capital Management, LLC New York, NY

4.91M
Shares

$48 Million
1.73% of portfolio
Tang Capital Management LLC San Diego, CA

4.89M
Shares

$47.8 Million
3.11% of portfolio
Vestal Point Capital, LP New York, NY

4.77M
Shares

$46.6 Million
2.4% of portfolio
Frazier Life Sciences Management, L.P. Menlo Park, CA

3.69M
Shares

$36 Million
2.3% of portfolio

View Full List

About KalVista Pharmaceuticals, Inc.

Ticker KALV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,602,000
Market Cap $240M
Description
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...

More about KALV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account